amractionfund.bsky.social
@amractionfund.bsky.social
"Investing in antibiotic innovation is not only a health priority but a strategic necessity to enhance Europe’s defence readiness," writes CEO Henry Skinner in a new op-ed focused on the rise of #AMR on the battlefields of #Ukraine. www.innovationnewsnetwork.com/russia-ukrai... #WAAW2025
November 20, 2025 at 12:51 PM
"Antibiotics were so transformative that within a generation we collectively forgot how devastating bacterial infections were for those who came before us," AMR Action Fund CEO Henry Skinner explained. #AMR #WAAW2025 via @contagionlive.bsky.social www.contagionlive.com/view/world-a...
November 19, 2025 at 1:23 PM
For #WAAW2025 we’re exploring how #AMR intersects with the defining challenges of our time, including #cancer.

Research shows people with cancer in inpatient & outpatient settings are at higher risk of developing AMR infections

Learn more: antimicrobialresistancefighters.org/cancer-and-a...
November 18, 2025 at 2:09 PM
#AMR poses an increasing threat to #rural communities in the U.S.

Our new white paper explores how workforce shortages, environmental exposures, and limited access to diagnostics and antibiotics, are amplifying infection risks across rural communities. www.amractionfund.com/blog/white-p...
October 23, 2025 at 4:55 PM
A new @who.int report finds that 1 in 6 lab-confirmed bacterial infections in 2023 were resistant to antibiotics. E. coli and K. pneumoniae are the leading drug-resistant Gram-negative bacteria found in bloodstream infections. www.who.int/news/item/13... #AMR
October 13, 2025 at 4:28 PM
For people with #cancer, infections have long been a scourge. The rise of #AMR is rapidly undermining cancer care, with studies showing that AMR rates for key pathogens are 1.2-5x greater in isolates from cancer outpatients vs non-cancer patients. antimicrobialresistancefighters.org/cancer-and-a...
October 8, 2025 at 12:31 PM
The @who.int released its new antibacterial pipeline analysis today and the findings are once again cause for concern. Total # of clinical-stage assets is down and only 11 agents are in development for critical priority pathogens. Read the full report www.statnews.com/wp-content/u... #AMR
October 2, 2025 at 3:32 PM